Press release
Presbyopia Pipeline Grows With 10+ Prominent Companies Targeting Novel Treatment Approaches | DelveInsight
Discover the latest drugs and treatment options in the Presbyopia Pipeline. Dive into DelveInsight's comprehensive report today! @ Presbyopia Pipeline Outlook [https://www.delveinsight.com/sample-request/presbyopia-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Presbyopia Pipeline Report
* In June 2025, Ocuphire Pharma Inc . announced a Phase 3 Study of the Safety and Efficacy of Nyxol (Phentolamine Ophthalmic Solution 0.75%) as a Single Agent and With Adjunctive Low-Dose Pilocarpine Hydrochloride Ophthalmic Solution 0.4% in Subjects With Presbyopia.
* In June 2025, Orasis Pharmaceuticals Ltd . conducted a study is to evaluate the safety of CSF-1 compared with vehicle in presbyopic subjects. Subjects will be treated for at least 6 weeks.
* DelveInsight's Presbyopia Pipeline report depicts a robust space with 10+ active players working to develop 10+ pipeline therapies for Presbyopia treatment.
* The leading Presbyopia Companies such as Visus Therapeutics, Glaukos Corporation, Cellix Bio, Orasis Pharmaceuticals, Cellix Bio and others.
* Promising Presbyopia Pipeline Therapies such as Phentolamine Ophthalmic Solution 0.75%, Pilocarpine, Pilocarpine HCl, UNR844-Cl, CSF-1, AGN-190584, Pilocarpine Ophthalmic, Aceclidine, Brimonidine and others.
Stay ahead with the most recent pipeline outlook for Presbyopia. Get insights into clinical trials, emerging therapies, and leading companies with Presbyopia @ Presbyopia Treatment Drugs [https://www.delveinsight.com/sample-request/presbyopia-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Presbyopia Emerging Drugs Profile
* LNZ100: Lenz Therapeutics
LNZ100 is a preservative-free, single-use, once-daily eye drop containing aceclidine, a selective muscarinic receptor agonist. It works by constricting the pupil, creating a pinhole effect that improves near vision. Unlike other pupil-constricting agents, aceclidine has a unique mechanism of action that decouples the miotic effect from the stimulation of the ciliary muscle, reducing the risk of myopic shift and accompanying brow ache. This allows LNZ100 to provide a broad patient population with a long-lasting and efficient treatment for presbyopia, a condition characterized by the gradual hardening of the lens and decline in near vision with age. US Food and Drug Administration (FDA) has accepted the Company's New Drug Application (NDA) for LNZ100 for the treatment of presbyopia. Currently, the drug is in registration stage of its clinical trial for the treatment of presbyopia.
* GLK-302: Glaukos Corporation
Glaukos Corporation is developing GLK-302, a sterile ophthalmic topical cream containing the active ingredient pilocarpine, for the treatment of presbyopia. GLK-302 is designed to be applied to the eyelid, allowing the pilocarpine to be delivered through the dermis to the eye. The mechanism of action involves pilocarpine, a muscarinic acetylcholine receptor agonist, which acts on the M3 and M1 receptors in the eye to cause pupillary constriction and increase the depth of focus, thereby improving near visual acuity in presbyopic patients without significantly deteriorating distance vision. Currently, the drug is in Phase II stage of its clinical trial for the treatment of presbyopia.
The Presbyopia Pipeline Report Provides Insights into-
* The report provides detailed insights about companies that are developing therapies for the treatment of Presbyopia with aggregate therapies developed by each company for the same.
* It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Presbyopia Treatment.
* Presbyopia Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
* Presbyopia Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
* Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Presbyopia market
Explore groundbreaking therapies and clinical trials in the Presbyopia Pipeline. Access DelveInsight's detailed report now! @ New Presbyopia Drugs [https://www.delveinsight.com/sample-request/presbyopia-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Presbyopia Companies
Visus Therapeutics, Glaukos Corporation, Cellix Bio, Orasis Pharmaceuticals, Cellix Bio and others.
Presbyopia pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
* Intra-articular
* Intraocular
* Intrathecal
* Intravenous
* Oral
* Parenteral
* Subcutaneous
* Topical
* Transdermal
Presbyopia Products have been categorized under various Molecule types such as
* Oligonucleotide
* Peptide
* Small molecule
Unveil the future of Presbyopia Treatment. Learn about new drugs, Presbyopia Pipeline developments, and key companies with DelveInsight's expert analysis @ Presbyopia Market Drivers and Barriers [https://www.delveinsight.com/sample-request/presbyopia-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Presbyopia Pipeline Report
* Coverage- Global
* Presbyopia Companies- Visus Therapeutics, Glaukos Corporation, Cellix Bio, Orasis Pharmaceuticals, Cellix Bio and others.
* Presbyopia Pipeline Therapies- Phentolamine Ophthalmic Solution 0.75%, Pilocarpine, Pilocarpine HCl, UNR844-Cl, CSF-1, AGN-190584, Pilocarpine Ophthalmic, Aceclidine, Brimonidine and others.
* Presbyopia Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
* Presbyopia Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Get the latest on Presbyopia Pipeline Therapies and clinical trials. Download DelveInsight's in-depth pipeline report today! @ Presbyopia Companies, Key Products and Unmet Needs [https://www.delveinsight.com/sample-request/presbyopia-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Contents
* Introduction
* Executive Summary
* Presbyopia: Overview
* Pipeline Therapeutics
* Therapeutic Assessment
* Presbyopia - DelveInsight's Analytical Perspective
* Late Stage Products (Registration)
* LNZ100: Lenz Therapeutics
* Drug profiles in the detailed report.....
* Mid Stage Products (Phase II)
* GLK-302: Glaukos Corporation
* Drug profiles in the detailed report.....
* Early Stage Products (Phase I)
* Drug Name: Company Name
* Preclinical Stage Products
* Drug Name: Company Name
* Drug profiles in the detailed report.....
* Inactive Products
* Presbyopia - Collaborations Assessment- Licensing / Partnering / Funding
* Presbyopia - Unmet Needs
* Presbyopia - Market Drivers and Barriers
* Appendix
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=presbyopia-pipeline-grows-with-10-prominent-companies-targeting-novel-treatment-approaches-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/presbyopia-pipeline-insight
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Presbyopia Pipeline Grows With 10+ Prominent Companies Targeting Novel Treatment Approaches | DelveInsight here
News-ID: 4090332 • Views: …
More Releases from ABNewswire
Hepatocellular Carcinoma Pipeline 2025: FDA Updates, Therapy Innovations, and Cl …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hepatocellular Carcinoma pipeline constitutes 90+ key companies continuously working towards developing 95+ Hepatocellular Carcinoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Hepatocellular Carcinoma Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Hepatocellular Carcinoma Market.
The Hepatocellular Carcinoma Pipeline report embraces…
Retired Judge Unveils Captivating Memoir of Grassroots Triumph Against Insurmoun …
Retired Judge Unveils Compelling Memoir of a Grassroots Victory Against the Odds GRASSROOTS Chronicles the Remarkable 1995 Campaign That Defied Political Convention and Reshaped Allegheny County's Judicial Landscape.
Judge Timothy Patrick O'Reilly (Ret.), a distinguished retired lawyer and judge and longtime Pittsburgh attorney with roots in South Fayette and Bridgeville, Pennsylvania, presents his memoir, GRASSROOTS: The Surprising Election of Judge Timothy Patrick O'Reilly. [https://a.co/d/fPnmneg] Born October 2, 1939, Judge O'Reilly draws…
Patio Elegance Brings Commercial-Grade Outdoor Kitchens and European Wellness De …
Patio Elegance establishes new standards for outdoor living by offering exclusively commercial-grade products built for decades of performance. The comprehensive collection spans professional kitchen islands and grills, authentic Lithuanian saunas, therapeutic cold plunges and jacuzzis, elegant gazebos, entertainment mancaves, and premium furniture all unified by European design excellence and institutional durability.
The outdoor living industry has long suffered from a quality gap, with most residential products failing to deliver the durability…
Andatel Grande Patong Phuket: Full Renovation Complete, Reopens Late March 2026
Andatel Grande Patong Phuket property: 122-room hotel across three buildings with iconic Olympic-size pool between two guest buildings, completely renovated after six-year COVID closure addressing extensive mold damage, all rooms 24 square meters with identical furniture/design.
PATONG, Phuket, Thailand - One of the best Andatel Grande Patong Phuket option in Phuket that is booked on Booking.com, Agoda, Hotels.com and more with free cancellation until 48 hours of check-in date that doesn't…
More Releases for Presbyopia
Presbyopia Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Presbyopia Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Presbyopia pipeline landscape. It covers the Presbyopia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Presbyopia pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Discover the latest drugs and treatment options in the Presbyopia…
Rising Geriatric Population Fuels Growth Of Myopia And Presbyopia Treatment Mark …
The Myopia and Presbyopia Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Myopia and Presbyopia Treatment Market Size and Projected Growth Rate?
The market size for myopia and presbyopia treatment has witnessed substantial growth over several recent years. The market is projected…
Myopia and Presbyopia Treatment Market: Addressing Vision Impairment Globally
The global market for myopia and presbyopia treatment has been witnessing remarkable growth, driven by the rising prevalence of vision impairment worldwide. As per recent findings from Transparency Market Research, the market was valued at approximately US$16.7 billion in 2021 and is projected to reach nearly US$45 billion by 2032, with a promising CAGR of 9.5% over the next decade. Corrective lenses emerge as the leading treatment type, with revenue…
Presbyopia Treatment Market Growth Analysis 2023-2030
Global Presbyopia Treatment Market Gains Momentum Amidst Rising Aging Population and Innovations in Therapeutics:
The global presbyopia treatment market has witnessed substantial growth in recent years, fueled by the increasing prevalence of presbyopia and the expanding aging population. Presbyopia, a common vision loss associated with aging, has prompted a surge in demand for effective treatments, leading to advancements in eyeglasses, contact lenses, surgeries, eye drops, and nutrient-based interventions.
Refractive surgeries, including Conductive…
Presbyopia Pipeline: Insights into Novel Pipeline Therapies, Key Pharma Companie …
DelveInsight's, "Presbyopia Pipeline Insight, 2022," report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Presbyopia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key takeaways from the Presbyopia Pipeline Insight Report
• Presbyopia Pipeline report offers a comprehensive…
Presbyopia Market 2020-2027 Sets the Table for Continued Growth || Top Growing C …
A transparent research method has been accomplished with the right tools and techniques to make this Presbyopia Market research report world-class. Two of the most widely used techniques namely SWOT analysis and Porter's Five Forces Analysis have been used while generating this report. Competitive analysis conducted in this report puts light on the moves of the key players in the Healthcare industry such as new product launches, expansions, agreements, joint…
